The outbreak of corona has led to the cooperation of domestic and international researchers to defeat the disease with the help of science and technology. Meanwhile, stem cells and regenerative medicine is one of the fields that has a great capacity for the production of vaccines and stem cell-based products to fight the disease.

Amir Ali Hamidieh, the secretary of the stem cell sciences and technologies development headquarter expressed about the field: academic researchers and knowledge-based companies have initiated activities in the field of stem cells and regenerative medicine, which involve various fields.

Hamidieh continued: a research team has conducted research on mesenchymal stem cells to treat corona. Academic professors and two knowledge-based companies have worked with each other to use the extraction of mesenchymal cells from four different sources to treat the disease. The results of these studies will be announced in the next few months.

He described corona treatment with a specific type of immune cell (NK Cell"s natural killer cells) as another study in which academics and knowledge-based professors collaborated.

The secretary of the stem cell sciences and technologies development headquarter announced research on corona vaccine, adding: a group of researchers are using intracellular manipulation to make a vaccine. However, making a vaccine is a complicated and time-consuming process. Work has begun on this. Of course, research is also being done on the production of antiviral drugs.

Pointing out one of the important measures taken by knowledge-based companies in the field of lab equipment to fight corona, Hamidieh asserted: a knowledge-based company has been able to design and construct non-invasive mechanical ventilators, which is more applicable and cheaper. The Department of Medical Equipment is currently reviewing the device.

A report by the public relations and information center of the Vice-Presidency for science and technology affairs